(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 17.07%189.32M | -16.64%367.05M | --161.71M | -0.01%440.33M | 21.59%440.36M | -3.18%362.15M | -11.10%132.59M | 10.36%374.04M | --149.15M | 36.81%338.92M |
Operating income | 17.07%189.32M | -16.64%367.05M | 161.71M | -0.01%440.33M | 21.59%440.36M | -3.18%362.15M | -11.10%132.59M | 10.36%374.04M | 149.15M | 36.81%338.92M |
Cost of sales | -18.71%-162.4M | 16.86%-293.96M | ---136.81M | 2.65%-353.56M | -27.63%-363.19M | 5.24%-284.57M | 12.39%-102.84M | -7.47%-300.31M | ---117.39M | -26.66%-279.43M |
Operating expenses | -18.71%-162.4M | 16.86%-293.96M | -136.81M | 2.65%-353.56M | -27.63%-363.19M | 5.24%-284.57M | 12.39%-102.84M | -7.47%-300.31M | -117.39M | -26.66%-279.43M |
Gross profit | 8.07%26.91M | -15.77%73.09M | 24.9M | 12.44%86.77M | -0.53%77.17M | 5.23%77.58M | -6.33%29.75M | 23.93%73.73M | 31.77M | 119.32%59.49M |
Selling expenses | -6.45%-4.6M | -18.72%-9.69M | ---4.32M | 20.04%-8.16M | -23.63%-10.21M | 13.67%-8.26M | 27.98%-3.22M | -17.55%-9.57M | ---4.47M | -21.45%-8.14M |
Administrative expenses | -9.54%-6.07M | 19.68%-12.21M | ---5.54M | -2.87%-15.2M | 33.50%-14.78M | -189.89%-22.22M | -235.08%-11.31M | 17.73%-7.67M | ---3.38M | -90.79%-9.32M |
Research and development expenses | -77.60%-6.66M | ---9.11M | ---3.75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | -46.01%-952K | 32.16%-1.19M | ---652K | -127.89%-1.76M | ---771K | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | -46.01%-952K | 32.16%-1.19M | ---652K | -127.89%-1.76M | ---771K | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | -58.22%3.61M | 0.15%9.11M | --8.65M | 662.46%9.1M | 15.87%-1.62M | -131.37%-1.92M | 7.12%3.23M | 213.57%6.13M | --3.02M | -170.29%-5.4M |
Operating profit | -36.53%12.24M | -29.33%50M | 19.28M | 42.07%70.75M | 10.21%49.8M | -27.85%45.18M | -31.48%18.46M | 70.92%62.62M | 26.94M | 170.52%36.64M |
Financing income | -19.56%2.73M | 196.86%7.56M | --3.4M | 21.41%2.55M | 1.26%2.1M | 204.11%2.07M | 99.72%717K | 42.77%681K | --359K | 35.90%477K |
Financing cost | 6.86%-190K | 69.90%-413K | ---204K | 12.56%-1.37M | -3.77%-1.57M | 41.64%-1.51M | 84.07%-282K | -8.18%-2.59M | ---1.77M | 0.25%-2.4M |
Earning before tax | -34.24%14.78M | -20.55%57.14M | 22.48M | 42.92%71.92M | 10.02%50.32M | -24.66%45.74M | -25.99%18.89M | 74.86%60.71M | 25.53M | 202.08%34.72M |
Tax | 59.72%-2.34M | 11.74%-15.83M | ---5.8M | -41.67%-17.94M | -14.74%-12.66M | 24.51%-11.03M | 30.26%-4.39M | -68.07%-14.62M | ---6.29M | -200.73%-8.7M |
After-tax profit from continuing operations | -25.38%12.45M | -23.47%41.31M | 16.68M | 43.33%53.98M | 8.52%37.66M | -24.71%34.71M | -24.59%14.51M | 77.13%46.1M | 19.24M | 202.53%26.02M |
Earning after tax | -25.38%12.45M | -23.47%41.31M | 16.68M | 43.33%53.98M | 8.52%37.66M | -24.71%34.71M | -24.59%14.51M | 77.13%46.1M | 19.24M | 202.53%26.02M |
Profit attributable to shareholders | -25.38%12.45M | -23.47%41.31M | 16.68M | 43.33%53.98M | 8.52%37.66M | -24.71%34.71M | -24.59%14.51M | 77.13%46.1M | 19.24M | 202.53%26.02M |
Basic earnings per share | -29.41%0.012 | -42.86%0.04 | 0.017 | 40.00%0.07 | 0.05 | |||||
Diluted earnings per share | -29.41%0.012 | -42.86%0.04 | 0.017 | 40.00%0.07 | 0.05 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | KPMG | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data